Expert Pitch

FDA to Decide on Alzheimer's Drug Approval - During National Alzheimer’s & Brain Awareness Month

Hackensack Meridian Health

It is estimated that someone in America will develop Alzheimer's disease every 67 seconds. As many as 500,000 new cases of Alzheimer's disease are expected to be diagnosed this year.

With no known cure, the Food & Drug Administration is anticipated to make a historic decision Monday, June 7 on whether to approve the first-ever treatment for mild cognitive decline and early-stage dementia caused by Alzheimer’s. 

The drug called Aducanumab is said to work by binding to the plaques between neurons and causing an immune response that removes them.

“That plaque is what is believed to gum up the brain in people who have the disease, so the long-held ‘amyloid theory’ suggests that if the plaque can be cleared away, cognition could improve, or at the very least, decline more slowly,” explained Manisha Parulekar, M.D., director, Division of Geriatrics, Hackensack Meridian Hackensack University Medical Center.

“Regardless of the FDA’s final decision, this is an important moment as we have never before been this close to approval of a medication for Alzheimer’s that could change the progression of the disease, not just the symptoms,” says Dr. Gary Small, chair of Psychiatry at Hackensack Meridian Health. 

Both Dr. Parulekar and Dr. Small can be available for comment. I can also get you in touch with the family of an Alzheimer's patient who is happy to share their story.

Mary McGeever, PR Manager, Hackensack University Medical Center

 

Filters close

Showing results

110 of 6022
Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

Released: 22-Jun-2021 11:15 AM EDT
Memoir from Health Policy Expert Challenges American Health Care System and Inspires Change
Amplify Publishing

Amplify Publishing announces the release of Beyond Fear: How I Fought the Feds for Six Years—and Won by Ted Giovanis.

Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
VIDEO
Released: 18-Jun-2021 2:10 PM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available
Newswise

Newswise is hosting a series of Expert Panels discussion on unique aspects of the COVID-19 pandemic. This tip sheet includes some notable quotes from the panelists.

Released: 16-Jun-2021 1:10 PM EDT
Establishing Juneteenth As National Holiday is Opportunity to Create "New America"
Binghamton University, State University of New York

The Senate has unanimously passed a bill to establish Juneteenth, a holiday commemorating the end of slavery in the United States, as a federal holiday. This is an historic moment and an opportunity to create a “new America,” according to Anne Bailey, professor of history at Binghamton University, State University of New York and director of the Harriet Tubman Center for the Study of Freedom and Equity.

Newswise: Keeping the peace
Released: 14-Jun-2021 5:55 PM EDT
Keeping the peace
Washington University in St. Louis

New research from Washington University in St. Louis sheds light on how — and in what context — peacekeepers can contain the spread of violence in fragile post-conflict areas.


Showing results

110 of 6022

close
1.89691